Spots Global Cancer Trial Database for advanced gastric carcinoma
Every month we try and update this database with for advanced gastric carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines | NCT04535401 | Advanced Colore... Advanced Digest... Advanced Gastri... Advanced Gastro... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Metastatic Colo... Metastatic Dige... Metastatic Gast... Metastatic Gast... Stage III Color... Stage IV Colore... | Biopsy Biospecimen Col... Diagnostic Imag... Elimusertib Fluorouracil Irinotecan Hydr... Leucovorin Calc... | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial | NCT04704661 | Advanced Breast... Advanced Colon ... Advanced Colore... Advanced Endome... Advanced Gastri... Advanced Gastro... Advanced Malign... Advanced Saliva... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... HER2-Positive B... Malignant Hepat... Metastatic Brea... Metastatic Gast... Metastatic Mali... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage III Colon... Stage III Color... Stage III Major... Stage III Uteri... Stage IIIA Colo... Stage IIIA Colo... Stage IIIA Uter... Stage IIIB Colo... Stage IIIB Colo... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Colo... Stage IIIC Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IV Colon ... Stage IV Colore... Stage IV Major ... Stage IV Uterin... Stage IVA Colon... Stage IVA Color... Stage IVA Major... Stage IVA Uteri... Stage IVB Colon... Stage IVB Color... Stage IVB Major... Stage IVB Uteri... Stage IVC Colon... Stage IVC Color... Stage IVC Major... Unresectable Co... Unresectable Ga... Unresectable Ma... | Ceralasertib Trastuzumab Der... | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines | NCT04535401 | Advanced Colore... Advanced Digest... Advanced Gastri... Advanced Gastro... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Metastatic Colo... Metastatic Dige... Metastatic Gast... Metastatic Gast... Stage III Color... Stage IV Colore... | Biopsy Biospecimen Col... Diagnostic Imag... Elimusertib Fluorouracil Irinotecan Hydr... Leucovorin Calc... | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer | NCT04491942 | Advanced Bile D... Advanced Breast... Advanced Cervic... Advanced Endome... Advanced Esopha... Advanced Gastri... Advanced Head a... Advanced Lung N... Advanced Lung S... Advanced Malign... Advanced Ovaria... Advanced Penile... Advanced Pleura... Advanced Urothe... Anatomic Stage ... Anatomic Stage ... Clinical Stage ... Clinical Stage ... Stage III Cervi... Stage III Dista... Stage III Intra... Stage III Lung ... Stage III Ovari... Stage III Penil... Stage III Pleur... Stage IV Cervic... Stage IV Distal... Stage IV Intrah... Stage IV Lung C... Stage IV Ovaria... Stage IV Penile... Stage IV Pleura... Triple-Negative... Unresectable Ur... | Cisplatin Elimusertib Gemcitabine Hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Prospectively Predict the Immunotherapy Response of Gastric Cancer Based on Circulating Exosomal LncRNA-GC1 Biopsy | NCT05334849 | Advanced Gastri... Immunotherapy | Circulating exo... | 18 Years - 80 Years | Chinese PLA General Hospital | |
| RC48 Plus AK105 and Cisplatin in Advanced Gastric Cancer | NCT05313906 | Advanced Gastri... HER2-positive G... | RC48+AK105+cisp... | 18 Years - 75 Years | Henan Cancer Hospital | |
| Safety of XELOX Combined With GLS-010 and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients | NCT05221775 | First-line Trea... Advanced Gastri... | Lenvatinib | 20 Years - | Tianjin Medical University Cancer Institute and Hospital | |
| Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines | NCT04535401 | Advanced Colore... Advanced Digest... Advanced Gastri... Advanced Gastro... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Metastatic Colo... Metastatic Dige... Metastatic Gast... Metastatic Gast... Stage III Color... Stage IV Colore... | Biopsy Biospecimen Col... Diagnostic Imag... Elimusertib Fluorouracil Irinotecan Hydr... Leucovorin Calc... | 18 Years - | National Cancer Institute (NCI) | |
| Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection | NCT01534546 | Advanced Gastri... | Oxaliplatin cap... Oxaliplatin S-1 Oxaliplatin S-1 | 18 Years - | Peking University | |
| Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric Adenocarcinoma | NCT04948125 | Advanced Gastri... | camrelizumab Apatinib Mesyla... | 18 Years - | Henan Cancer Hospital | |
| Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection | NCT01534546 | Advanced Gastri... | Oxaliplatin cap... Oxaliplatin S-1 Oxaliplatin S-1 | 18 Years - | Peking University | |
| The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Gastric Cancer | NCT05351398 | Advanced Gastri... | PDO group Traditional gro... | 18 Years - 80 Years | Shanghai Minimally Invasive Surgery Center | |
| A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma | NCT00192088 | Advanced Gastri... | pemetrexed oxaliplatin | 18 Years - | Eli Lilly and Company | |
| Clinical Efficacy of Trastuzumab in Combination With Capecitabine and Oxaliplatin for the Treatment of HER2-positive Advanced Gastric Cancer. | NCT05997524 | Advanced Gastri... | Trastuzumab Oxaliplatin Capecitabine | 18 Years - | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | |
| Use of Circulating Exosomal LncRNA-GC1 to Monitor Gastric Cancer | NCT05397548 | Gastric Cancer | Measurement of ... | 18 Years - 80 Years | Chinese PLA General Hospital | |
| Total Neoadjuvant Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer | NCT06028737 | Gastric Cancer Stomach Cancer GastroEsophagea... Gastric Adenoca... Gastroesophagea... Advanced Gastri... Gastric Neoplas... Stomach Neoplas... Gastrointestina... Advanced Gastro... Advanced Gastri... | Docetaxel Oxaliplatin Leucovorin Fluorouracil | 18 Years - 80 Years | Ukrainian Society of Clinical Oncology | |
| Neo-adjuvant Chemotherapy Evluation in Gastric Cancer Patients Based on Circulating Exosomal LncRNA-GC1 | NCT05647941 | Gastric Cancer Chemotherapy Ef... | Detection of le... | 18 Years - 80 Years | Chinese PLA General Hospital | |
| IMM2902 in Patients With Advanced Solid Tumors Expressing HER2 | NCT05805956 | Advanced Solid ... Advanced Lung C... Advanced Gastri... Advanced Cholan... | IMM2902 | 18 Years - 75 Years | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | |
| Prospectively Predict the Immunotherapy Response of Gastric Cancer Based on Circulating Exosomal LncRNA-GC1 Biopsy | NCT05334849 | Advanced Gastri... Immunotherapy | Circulating exo... | 18 Years - 80 Years | Chinese PLA General Hospital | |
| A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Gastric Carcinoma | NCT04718402 | Advanced Gastri... | Mitoxantrone Hy... | 18 Years - | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric Adenocarcinoma | NCT04948125 | Advanced Gastri... | camrelizumab Apatinib Mesyla... | 18 Years - | Henan Cancer Hospital | |
| Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T | NCT05620732 | Advanced Pancre... Advanced Gastri... | Claudin18.2 CAR... | 18 Years - 75 Years | Shenzhen University General Hospital | |
| Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection | NCT01534546 | Advanced Gastri... | Oxaliplatin cap... Oxaliplatin S-1 Oxaliplatin S-1 | 18 Years - | Peking University | |
| Prospective Study on Double-Stapling End-to-End Gastroduodenostomy Billroth-I Anastomosis in Laparoscopy-Assisted Surgery for Locally Advanced Distal Gastric Cancers | NCT05545293 | Advanced Gastri... | 18 Years - 85 Years | West China Hospital | ||
| At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer | NCT05969860 | Advanced Anal C... Advanced Biliar... Advanced Bladde... Advanced Breast... Advanced Carcin... Advanced Cervic... Advanced Colore... Advanced Gastri... Advanced Gliobl... Advanced Head a... Advanced HER2 P... Advanced Lung C... Advanced Lung S... Advanced Malign... Advanced Malign... Advanced Neuroe... Advanced Ovaria... Advanced Pancre... Advanced Prosta... Advanced Prosta... Hematopoietic a... Multiple Myelom... Myelodysplastic... | Clinical Encoun... Home Health Enc... Quality-of-Life... Questionnaire A... | 18 Years - | Mayo Clinic | |
| Study on Neoadjuvant Chemotherapy for Advanced Gastric Cancer | NCT02163291 | Advanced Gastri... | paclitaxel lipo... | 18 Years - 75 Years | Peking University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
